Stay updated with breaking news from Nasdaq Krtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $300.00 target price on the stock. Several other research firms also recently weighed in on KRTX. Cantor Fitzgerald reiterated a neutral rating and […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) insider Stephen K. Brannan sold 5,000 shares of the business’s stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $184.04, for a total transaction of $920,200.00. Following the sale, the insider now directly owns 28,650 shares of the company’s […]
ARCH Venture Management LLC reduced its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 94.2% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,000 shares of the company’s stock after selling 482,872 shares during the quarter. Karuna […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) insider Stephen K. Brannan sold 5,000 shares of Karuna Therapeutics stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $184.04, for a total transaction of $920,200.00. Following the transaction, the insider now owns 28,650 shares of the company’s stock, […]
MYDA Advisors LLC purchased a new stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 8,000 shares of the company’s stock, valued at approximately $1,453,000. Several other hedge funds have also recently made changes […]